These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 12453895)
1. Y2 receptor deletion attenuates the type 2 diabetic syndrome of ob/ob mice. Sainsbury A; Schwarzer C; Couzens M; Herzog H Diabetes; 2002 Dec; 51(12):3420-7. PubMed ID: 12453895 [TBL] [Abstract][Full Text] [Related]
2. Important role of hypothalamic Y2 receptors in body weight regulation revealed in conditional knockout mice. Sainsbury A; Schwarzer C; Couzens M; Fetissov S; Furtinger S; Jenkins A; Cox HM; Sperk G; Hökfelt T; Herzog H Proc Natl Acad Sci U S A; 2002 Jun; 99(13):8938-43. PubMed ID: 12072562 [TBL] [Abstract][Full Text] [Related]
3. Hypothalamic control of bone formation: distinct actions of leptin and y2 receptor pathways. Baldock PA; Sainsbury A; Allison S; Lin EJ; Couzens M; Boey D; Enriquez R; During M; Herzog H; Gardiner EM J Bone Miner Res; 2005 Oct; 20(10):1851-7. PubMed ID: 16160743 [TBL] [Abstract][Full Text] [Related]
4. Adrenalectomy reverses obese phenotype and restores hypothalamic melanocortin tone in leptin-deficient ob/ob mice. Makimura H; Mizuno TM; Roberts J; Silverstein J; Beasley J; Mobbs CV Diabetes; 2000 Nov; 49(11):1917-23. PubMed ID: 11078460 [TBL] [Abstract][Full Text] [Related]
5. NPY neuron-specific Y2 receptors regulate adipose tissue and trabecular bone but not cortical bone homeostasis in mice. Shi YC; Lin S; Wong IP; Baldock PA; Aljanova A; Enriquez RF; Castillo L; Mitchell NF; Ye JM; Zhang L; Macia L; Yulyaningsih E; Nguyen AD; Riepler SJ; Herzog H; Sainsbury A PLoS One; 2010 Jun; 5(6):e11361. PubMed ID: 20613867 [TBL] [Abstract][Full Text] [Related]
6. PYY transgenic mice are protected against diet-induced and genetic obesity. Boey D; Lin S; Enriquez RF; Lee NJ; Slack K; Couzens M; Baldock PA; Herzog H; Sainsbury A Neuropeptides; 2008 Feb; 42(1):19-30. PubMed ID: 18164057 [TBL] [Abstract][Full Text] [Related]
7. Fasting inhibits the growth and reproductive axes via distinct Y2 and Y4 receptor-mediated pathways. Lin S; Lin EJ; Boey D; Lee NJ; Slack K; During MJ; Sainsbury A; Herzog H Endocrinology; 2007 May; 148(5):2056-65. PubMed ID: 17272395 [TBL] [Abstract][Full Text] [Related]
8. Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Schwartz MW; Baskin DG; Bukowski TR; Kuijper JL; Foster D; Lasser G; Prunkard DE; Porte D; Woods SC; Seeley RJ; Weigle DS Diabetes; 1996 Apr; 45(4):531-5. PubMed ID: 8603777 [TBL] [Abstract][Full Text] [Related]
9. Effect of a fatty acid synthase inhibitor on food intake and expression of hypothalamic neuropeptides. Shimokawa T; Kumar MV; Lane MD Proc Natl Acad Sci U S A; 2002 Jan; 99(1):66-71. PubMed ID: 11756683 [TBL] [Abstract][Full Text] [Related]
10. Age-dependent hypothalamic expression of neuropeptides in wild-type and melanocortin-4 receptor-deficient mice. Arens J; Moar KM; Eiden S; Weide K; Schmidt I; Mercer JG; Simon E; Korf HW Physiol Genomics; 2003 Dec; 16(1):38-46. PubMed ID: 14559977 [TBL] [Abstract][Full Text] [Related]
11. Voluntary exercise prevents the obese and diabetic metabolic syndrome of the melanocortin-4 receptor knockout mouse. Haskell-Luevano C; Schaub JW; Andreasen A; Haskell KR; Moore MC; Koerper LM; Rouzaud F; Baker HV; Millard WJ; Walter G; Litherland SA; Xiang Z FASEB J; 2009 Feb; 23(2):642-55. PubMed ID: 18971258 [TBL] [Abstract][Full Text] [Related]
12. Combined deletion of Y1, Y2, and Y4 receptors prevents hypothalamic neuropeptide Y overexpression-induced hyperinsulinemia despite persistence of hyperphagia and obesity. Lin EJ; Sainsbury A; Lee NJ; Boey D; Couzens M; Enriquez R; Slack K; Bland R; During MJ; Herzog H Endocrinology; 2006 Nov; 147(11):5094-101. PubMed ID: 16873543 [TBL] [Abstract][Full Text] [Related]
13. Decreased plasma peptide YY accompanied by elevated peptide YY and Y2 receptor binding densities in the medulla oblongata of diet-induced obese mice. Rahardjo GL; Huang XF; Tan YY; Deng C Endocrinology; 2007 Oct; 148(10):4704-10. PubMed ID: 17615145 [TBL] [Abstract][Full Text] [Related]
15. Hyperleptinemia in A(y)/a mice upregulates arcuate cocaine- and amphetamine-regulated transcript expression. Tsuruta Y; Yoshimatsu H; Hidaka S; Kondou S; Okamoto K; Sakata T Am J Physiol Endocrinol Metab; 2002 Apr; 282(4):E967-73. PubMed ID: 11882520 [TBL] [Abstract][Full Text] [Related]
16. Attenuation of hypercholesterolemia and hyperglycemia in ob/ob mice by NPY Y2 receptor ablation. Naveilhan P; Svensson L; Nyström S; Ekstrand AJ; Ernfors P Peptides; 2002 Jun; 23(6):1087-91. PubMed ID: 12126735 [TBL] [Abstract][Full Text] [Related]
17. Induction of neuropeptide Y gene expression in the dorsal medial hypothalamic nucleus in two models of the agouti obesity syndrome. Kesterson RA; Huszar D; Lynch CA; Simerly RB; Cone RD Mol Endocrinol; 1997 May; 11(5):630-7. PubMed ID: 9139806 [TBL] [Abstract][Full Text] [Related]
18. Chronic administration of neuropeptide Y into the lateral ventricle of C57BL/6J male mice produces an obesity syndrome including hyperphagia, hyperleptinemia, insulin resistance, and hypogonadism. Raposinho PD; Pierroz DD; Broqua P; White RB; Pedrazzini T; Aubert ML Mol Cell Endocrinol; 2001 Dec; 185(1-2):195-204. PubMed ID: 11738809 [TBL] [Abstract][Full Text] [Related]
19. Impact of glucose infusion on the structural and functional characteristics of adipose tissue and on hypothalamic gene expression for appetite regulatory neuropeptides in the sheep fetus during late gestation. Mühlhäusler BS; Adam CL; Marrocco EM; Findlay PA; Roberts CT; McFarlane JR; Kauter KG; McMillen IC J Physiol; 2005 May; 565(Pt 1):185-95. PubMed ID: 15661821 [TBL] [Abstract][Full Text] [Related]
20. Y2 receptor signalling in NPY neurons controls bone formation and fasting induced feeding but not spontaneous feeding. Qi Y; Fu M; Herzog H Neuropeptides; 2016 Feb; 55():91-7. PubMed ID: 26444586 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]